News
Paul Cauthen is making it clear that he is determined not to slow down or back down as he battles cancer. The country music singer shared a handful of Instagram stories across the past week that ...
Ian Smith, known as Harold Bishop in 'Neighbours', diagnosed with rare lung cancer: pulmonary pleomorphic carcinoma. Describes his diagnosis as a 'cruel, ugly, brutal place' with a feeling of ...
People with the hereditary disease familial adenomatous polyposis (FAP) have a greatly increased risk of developing a malignant tumor of the duodenum. Researchers have now discovered a mechanism in ...
Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...
Podium presentation showcases the clinical application of Preciseâ„¢ MRDSALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) -- ...
16h
Stocktwits on MSNSummit Therapeutics Stock Slumps After Partner Akeso Gets FDA Nod For Cancer Drug: Retail’s OptimisticSummit Therapeutics stock tumbled 37% on Friday afternoon after the U.S. Food and Drug Administration (FDA) approved its ...
Akeso Inc. scored U.S. FDA approval of the PD-1 monoclonal antibody penpulimab in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or ...
Agenus Inc. (Nasdaq: AGEN), a clinical-stage immuno-oncology company, today announced updated data from the hepatocellular carcinoma (HCC) cohort of its ongoing Phase 1 study evaluating botensilimab ...
Summit Therapeutics (SMMT) stock plunges 35% a day after the FDA approval of partner Akeso's (AKESF) cancer drug, ...
Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck ...
Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...
Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results